|
Company |
Type of Project |
Support Provided |
Alternatives Considered |
Final Selections |
Reported Economic Impact |
Reported Strategic Impact |
Reported Incentives |
Project Timing |
Feedback |
|
Highlights |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
Medical Device and Healthcare
Products |
Project |
Support |
Alternatives |
Selected |
Parameters |
Impact |
Incentives |
Timing |
Feedback |
|
Varian Medical Systems |
Expansion |
EDCUtah |
|
Salt Lake City, Utah |
100-250 jobs
$10 million
70,000 sq ft |
flat-panel digital X-ray image detectors |
TIF |
Announced August 2005, by Dec 2006 |
|
|
Kendall Co. |
new plant |
none |
|
Deland Florida |
$90 million |
medical needle manufacturing |
|
|
|
|
Medline Industries |
|
none |
|
Lathrop
California |
|
medical products |
|
|
|
|
Medline Industries |
|
none |
|
Aberdeen
Maryland |
$12 million |
medical products |
|
|
|
|
1888 Mills |
|
none |
|
Thomaston
Georgia |
|
|
|
|
|
|
Atrix Laboratories |
expanded plant |
none |
|
Fort Collins
Colorado |
|
medical products |
|
|
|
|
Biotechnology |
Project |
Support |
Alternatives |
Selected |
Parameters |
Impact |
Incentives |
Timing |
Feedback |
|
Protein Design Labs |
|
none |
|
Plymouth Minnesota |
$200 million |
|
|
|
|
|
Serologicals Corp. |
|
none |
|
Lawrence
Kansas |
$28 million |
|
|
|
|
|
Pharmaceutical |
Project |
Support |
Alternatives |
Selected |
Parameters |
Impact |
Incentives |
Timing |
Feedback |
|
Eli Lilly |
new plant |
none |
|
Prince William County
Virginia |
up
to 700 jobs, $1 billion capital investment |
synthetic insulin production and other pharmaceuticals |
|
|
|
|
Immunex |
new plant |
none |
|
West Greenwich
Rhode
Island |
350 jobs, $500 million capital investment |
manufacture new drug for rheumatoid arthritis |
|
2005 |
|
|
Human Genome Sciences |
|
none |
|
Rockville Maryland |
$100 million |
drug manufacturing |
|
|
|
|
Elan Corp. |
expanded plant |
none |
|
Gainesville
Georgia |
$40 million |
|
|
|
|
|
Abbott Laboratories |
new plant |
none |
|
McPherson
Kansas |
$50 million |
|
|
|
|
|
Shire Pharmaceuticals Group |
|
none |
|
Owings Mills Maryland |
$17 million |
|
|
|
|
|
Pamlab |
|
none |
|
Shreveport
Louisiana |
$25 million |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
Explanation |
Project |
Support |
Alternatives |
Selected |
Parameters |
Impact |
Incentives |
Timing |
Feedback |
|
Example, Name, link to website and PR
if available |
New
or expanded
facility size, location |
Summary of needs which were met for the project |
known short list locations,
and services considered or used to support project plans |
locations and final service providers chosen to implement the project |
Jobs, $,
technology transfer, etc. in location |
Significance to company
global strategy, performance,
operations |
As disclosed,
and who to contact to discuss directly |
announced, occupancy, expected expansion,
actual expansion |
Lessons learned, proven solutions etc. |
| Example
- highlight
Link to full project
profile if available - see Template |
Expand, Relocate office
or factory |
consultants used for site selection or other support |
usually not reported in other channels, but can offer useful insight into
choices |
Link to Area Profile or Service if available, or website, and
regional table of contacts |
The reported parameters
may not be reliable
for industry or regional trend analysis |
Why did the project happen now? What is the purpose? Routine
growth, or something really new? Local or global? |
Details are seldom published;
total reported value may be misleading |
Note that the same project may get repeated PR / media coverage |
potential links to testimonials or other feedback |
| |
|
|
|
|
|
|
|
|
|
Add our site search tool to your iGoogle page
